Centers for Disease Control and Prevention
Date: November 2011
Purpose: to develop a substantially more phenotypically stable live, attenuated type 2 OPV strain suitable for use by the WHO Global Polio Eradication Initiative (GPEI)
Amount: $1,682,661
Term: 3 years
Grantee Location: Atlanta, Georgia
Grantee Web site: Not available